Kaposi sarcoma-associated herpesvirus (KSHV) is involved in the etiopathogenesis of Kaposi sarcoma and certain lymphoproliferative disorders. Open reading frame (ORF) 73 encodes the main immunogenic latent nuclear antigen (LNA-1) of KSHV. LNA-1 maintains the KSHV episome and tethers the viral genome to chromatin during mitosis. In addition, LNA-1 interacts with p53 and represses its transcriptional activity. Here we show that LNA-1 also interacts with the retinoblastoma protein. LNA-1 transactivated an artificial promoter carrying the cell cycle transcription factor E2F DNA-binding sequences and also upregulated the cyclin E (CCNE1) promoter, but not the B-myb (MYBL2) promoter. LNA-1 overcame the flat-cell phenotype induced by retinoblastoma protein in Saos2 cells. In cooperation with the cellular oncogene Harvey rat sarcoma viral oncogene homolog (Hras), LNA-1 transformed primary rat embryo fibroblasts and rendered them tumorigenic. These findings indicate that LNA-1 acts as a transcription co-factor and may contribute to KSHV-induced oncogenesis by targeting the retinoblastoma protein–E2F transcriptional regulatory pathway
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F80459/MediaObjects/41591_2000_Article_BFnm1000_1121_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F80459/MediaObjects/41591_2000_Article_BFnm1000_1121_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F80459/MediaObjects/41591_2000_Article_BFnm1000_1121_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F80459/MediaObjects/41591_2000_Article_BFnm1000_1121_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F80459/MediaObjects/41591_2000_Article_BFnm1000_1121_Fig5_HTML.gif)
References
Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865– 1869 (1994).
Cesarman, E., Chang, Y., Moore, P.S., Said, J.W. & Knowles, D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186–1191 ( 1995).
Soulier, J. et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276–1280 (1995).
Dupin, N. et al. HHV-8 is associated with a plasmablastic variant of Castleman's disease that is linked to HHV-8 positive plasmablastic lymphoma. Blood 95, 1406–1412 ( 2000).
Boshoff, C. et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med. 1, 1274– 1278 (1995).
Staskus, K.A. et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71, 715–719 (1997).
Sturzl, M. et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 20, 1725–1733 (1999).
Dupin, N. et al. Distribution of HHV-8 positive cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA 96, 4546–4551 (1999).
Staskus, K.A. et al. Cellular tropism and viral interleukin-6 expresion distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J. Virol. 73, 4181–4187 (1999).
Parravicini, C. et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. Am. J. Pathol. 156, 743–749 (2000).
Cesarman, E. et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences . Blood 86, 2708–2714 (1995).
Boshoff, C. et al. Establishment of a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in vivo. Blood 91, 1671–1679 (1998).
Panyutich, E.A., Said, J.W. & Miles, S.A. Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS 12, 467–472 ( 1998).
Flore, O. et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588–592 (1998).
Moses, A.V. et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73, 6892–6902 (1999).
Whyte, P. et al. Association between an ancogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124–128 (1988).
DeCaprio, J.A. et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275–283 (1988).
Dyson, N., Howley, P.M., Munger, K. & Harlow, E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934– 937 (1989).
Chellappan, S. et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89, 4549–4553 ( 1992).
Rainbow, L. et al. The 222–234 kd nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf 73 and a component of the latency-associated nuclear antigen. J. Virol. 71 , 5915–5921 (1997).
Kellam, P. et al. Identification of a major latent nuclear antigen (LNA-1) in the human herpesvirus 8 (HHV-8) genome. J. Hum. Virol. 1, 19–29 (1997).
Kedes, D.H., Lagunoff, M., Renne, R. & Ganem, D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100 , 2606–2610 (1997).
Kellam, P. et al. Characterising monoclonal antibodies against KSHV latent nuclear antigen (LNA-1). J. Virol. 73, 5149– 5155 (1999).
Ballestas, M.E., Chatis, P.A. & Kaye, K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641–644 ( 1999).
Cotter, M.A. & Robertson, E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-asociated herpesvirus genome to host chromosomes in body-cavity-based lymphoma cells. Virology 264, 254–264 ( 1999).
Russo, J.J. et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93, 14862 –14867 (1996).
Zamanian, M. & La Thangue, N.B. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J. 11, 2603–2610 (1992).
Keyomarsi, K., Conte, D. Jr., Toyofuku, W. & Fox, M.P. Deregulation of cyclin E in breast cancer. Oncogene 11, 941–950 ( 1995).
Le Cam, L. et al. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J. 18, 1878–1890 ( 1999).
Hurford, R.K.J., Cobrinik, D., Lee, M.H. & Dyson, N. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447–1463 (1997).
Bennett, J.D., Farlie, P.G. & Watson, R.J. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene 13, 1073–1082 ( 1996).
Lam, E.W. et al. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J. 13, 871–878 (1994).
Hinds, P.W. et al. Regulation of retinoblatoma functions by ectopic expression of human cyclins. Cell 70, 993– 1006 (1992).
Brehm, A. et al. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18, 2449–2458 (1999).
Chang, Y. et al. Cyclin encoded by KS herpesvirus. Nature 382, 410 (1996).
Hamburger, A.W. & Salmon, S.E. Development of a bioassay for human myeloma colony-forming cells. Prog. Clin. Biol. Res. 48, 23–41 ( 1980).
Gao, S.-J. et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signalling pathway. Oncogene 15, 1979– 1985 (1997).
Bais, C. et al. Kaposi's sarcoma associated herpesvirus (KSHV/HHV-8) G protein-coupled receptor is a viral oncogene and angiogenesis activator. Nature 391, 86–89 ( 1998).
Lee, H. et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med. 4, 435– 440 (1998).
Friborg Jr, J., Kong, W., Hottiger, M.O. & Nabel, G.J. p53 inhibition by LANA protein of KSHV protects against cell death. Nature 402, 889–894 ( 1999).
Ludlow, J.W. Interactions between SV40 large-tumor antigen and the growth suppresor proteins pRb and p53. FASEB J. 7, 866– 871 (1993).
Thomas, J.T., Hubert, W.G., Ruesch, M.N. & Laimins, L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. USA 96, 8449– 8454 (1999).
Boshoff, C. Coupling herpesvirus to angiogenesis: Viral pirates on a cellular sea. Nature 391, 24–25 ( 1998).
Treisman, R., Novak, U., Favaloro, J. & Kamen, R. Transformation of rat cells by an altered polyomavirus genome expressing only the middle-T protein. Nature 292, 595– 600 (1981).
Radkov, S.A. et al. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21 . J. Virol. 71, 8552–8562 (1997).
Acknowledgements
This work was supported by The Cancer Research Campaign, The UK Medical Research Council and Glaxo Wellcome. We thank T. Sharp and J.-B. Rascle for discussions, R. Weiss for critical reading of the manuscript, and D. Bourboulia, M.-Q. Du and N. Phillips for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radkov, S., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6, 1121–1127 (2000). https://doi.org/10.1038/80459
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/80459
This article is cited by
-
Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi’s sarcoma-associated herpes virus
Cellular Oncology (2022)
-
Designer nucleases to treat malignant cancers driven by viral oncogenes
Virology Journal (2021)
-
Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease
Seminars in Immunopathology (2020)
-
Latent infection with Kaposi’s sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1
Oncogene (2019)
-
Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis
Virologica Sinica (2019)